Legal & General Group’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-442
Closed -$9.68K 3481
2024
Q1
$9.68K Sell
442
-155
-26% -$3.44K ﹤0.01% 3208
2023
Q4
$11.6K Hold
597
﹤0.01% 3204
2023
Q3
$11K Hold
597
﹤0.01% 3249
2023
Q2
$11K Buy
+597
New +$14.1K ﹤0.01% 3302
2021
Q2
Sell
-258
Closed -$14K 3603
2021
Q1
$14K Hold
258
﹤0.01% 3283
2020
Q4
$16K Hold
258
﹤0.01% 3175
2020
Q3
$15K Sell
258
-79
-23% -$5.85K ﹤0.01% 3080
2020
Q2
$38K Buy
337
+63
+23% +$4.48K ﹤0.01% 2807
2020
Q1
$18K Sell
274
-79
-22% -$7.96K ﹤0.01% 2944
2019
Q4
$49K Buy
353
+75
+27% +$9.73K ﹤0.01% 2819
2019
Q3
$29K Hold
278
﹤0.01% 2982
2019
Q2
$27K Buy
278
+80
+40% +$10.5K ﹤0.01% 3080
2019
Q1
$31K Hold
198
﹤0.01% 2913
2018
Q4
$18K Hold
198
﹤0.01% 3119
2018
Q3
$37K Buy
198
+39
+25% +$11.1K ﹤0.01% 2922
2018
Q2
$67K Buy
159
+96
+152% +$32.4K ﹤0.01% 2622
2018
Q1
$19K Hold
63
﹤0.01% 3124
2017
Q4
$18K Buy
+63
New +$17.7K ﹤0.01% 3158

Other funds holding OPTN

Legal & General Group's OPTN Position: Q2 2024 in Review

Legal & General Group sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 442 shares — an estimated $9.68K sold.

Legal & General Group first reported a position in OPTN in Q4 2017 and held it in 18 quarters. The position peaked at $67K in Q2 2018. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • Legal & General Group reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 442 OptiNose shares in Q2 2024, an estimated $9.68K.
  • Legal & General Group first reported a position in OptiNose in Q4 2017 and held it in 18 quarters.
  • Legal & General Group's OptiNose position peaked at $67K in Q2 2018.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.